Cite
NLRP3 and cancer: Pathogenesis and therapeutic opportunities.
MLA
Tengesdal, Isak W., et al. “NLRP3 and Cancer: Pathogenesis and Therapeutic Opportunities.” Pharmacology & Therapeutics, vol. 251, Nov. 2023, p. 108545. EBSCOhost, https://doi.org/10.1016/j.pharmthera.2023.108545.
APA
Tengesdal, I. W., Dinarello, C. A., & Marchetti, C. (2023). NLRP3 and cancer: Pathogenesis and therapeutic opportunities. Pharmacology & Therapeutics, 251, 108545. https://doi.org/10.1016/j.pharmthera.2023.108545
Chicago
Tengesdal, Isak W, Charles A Dinarello, and Carlo Marchetti. 2023. “NLRP3 and Cancer: Pathogenesis and Therapeutic Opportunities.” Pharmacology & Therapeutics 251 (November): 108545. doi:10.1016/j.pharmthera.2023.108545.